Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Archiv Der Pharmazie|September 1, 2007
Pharmacokinetic profile of atenolol aspirinateAna C Montes-Gil, Marcos Zanfolin, Cristina E Okuyama, et al.European Journal of Medicinal Chemistry|January 29, 2016
Synthesis, in vitro and in vivo pharmacological evaluation of serotoninergic ligands containing an isonicotinic nucleusFerdinando Fiorino, Antonio Ciano, Elisa Magli, et al.Molecular Pharmacology|October 16, 2012
Neurounina-1, a novel compound that increases Na+/Ca2+ exchanger activity, effectively protects against stroke damagePasquale Molinaro, Maria Cantile, Ornella Cuomo, et al.Bioorganic & Medicinal Chemistry|September 26, 2017
New 5-HT<sub>1A</sub>, 5HT<sub>2A</sub> and 5HT<sub>2C</sub> receptor ligands containing a picolinic nucleus: Synthesis, in vitro and in vivo pharmacological evaluationFerdinando Fiorino, Elisa Magli, Ewa Kędzierska, et al.Molecular Neurobiology|February 13, 2020
Genetic Up-Regulation or Pharmacological Activation of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger 1 (NCX1) Enhances Hippocampal-Dependent Contextual and Spatial Learning and MemorySilvia Natale, Serenella Anzilotti, Tiziana Petrozziello, et al.Chemmedchem|June 3, 2025
Novel 4,5-Dihydrothiazole-Phenylpiperazine Derivatives: Synthesis, Docking Studies and Pharmacological Evaluation as Serotonergic AgentsGiorgia Andreozzi, Natalia Karkoszka, Rosa Sparaco, et al.ACS Chemical Neuroscience|May 6, 2015
Pharmacological characterization of the newly synthesized 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride (BED) as a potent NCX3 inhibitor that worsens anoxic injury in cortical neurons, organotypic hippocampal cultures, and ischemic brainAgnese Secondo, Giuseppe Pignataro, Paolo Ambrosino, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2025
Novel 1,4-benzothiazepin-2-one modulators of NCX3 as a promising strategy for neuroprotection in cerebral ischemiaAntonia Scognamiglio, Angela Corvino, Agata Zięba, et al.Molecules (Basel, Switzerland)|October 16, 2025
1,2,4-Thiadiazolidin-3,5-Diones as Inhibitors of Cysteine ProteasesMaria Aparecida Juliano, Marco Persico, Beatrice Severino, et al.Archiv Der Pharmazie|February 5, 2021
Synthesis, docking studies, and pharmacological evaluation of 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligandsElisa Magli, Ewa Kędzierska, Agnieszka A Kaczor, et al.Pageof 10